Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for postoperative sleep disturbance after maxillofacial surgery
ChiCTR2100049632Phase 4Recruiting
- Sponsor
- Plastic Surgery Hospital of Chinese Academy of Medical Sciences
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam in Postoperative sleep disturbance (PSD) (5 arms), sponsored by Plastic Surgery Hospital of Chinese Academy of Medical Sciences. Primary endpoint: Sleep rhythm. Started Aug 2021; status: recruiting.
02
Drugs
remimazolam
03
Conditions
Postoperative sleep disturbance (PSD)
Beyond the preview
Go deeper on ChiCTR2100049632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049632.